Novo Nordisk Pharma GmbH v S.

European Union – Consumer protection. The Court of Justice of the European Union ruled that Directive (EEC) 85/374 (on the approximation of the laws, regulations and administrative provisions of the Member States concerning liability for defective products), as amended, should be interpreted as not precluding national legislation — such as that at issue in the main proceedings, establishing a special liability system for the purposes of art 13 of that directive — under which, in consequence of an amendment to that legislation made after the directive had been notified to the member state concerned, the consumer had the right to require the manufacturer of the medicinal product to provide him with information on the adverse effects of that product.

Category: